Announcements
- EQS-News: Epigenomics AG: Executive Board member Jens Ravens leaves the Company on April 30, 2024
- EQS-NVR: Epigenomics AG: Release according to Article 41 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution
- EQS-News: Epigenomics AG publishes financial results for fiscal year 2023
- EQS-AFR: Epigenomics AG: Preliminary announcement of the publication of financial reports according to Articles 114, 115, 117 of the WpHG [the German Securities Act]
- EQS-News: Epigenomics AG: Jochen Hummel appointed to the Supervisory Board to replace Heikki Lanckriet
More ▼
Key statistics
Short selling activityProvided by S&P Global Market Intelligence
Open | -- |
---|---|
High | -- |
Low | -- |
Bid | -- |
Offer | -- |
Previous close | -- |
Average volume | -- |
---|---|
Shares outstanding | 875.15k |
Free float | 584.34k |
P/E (TTM) | -- |
Market cap | 1.42m EUR |
EPS (TTM) | -19.49 EUR |
Data delayed at least 15 minutes, as of Dec 30 1899.
More ▼